Clinical Trial Update: Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial [Phase 2]

View source ↗

Summary

Phase 2 multicenter interventional trial evaluating romiplostim combined with glucocorticoids as first-line therapy for newly diagnosed adult primary immune thr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Glucocorticoids (steroids) (glucocorticoids)
• Romiplostim (romiplostim)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Primary Immune Thrombocytopenia (ITP) | Phase 2 | Status: RECRUITING